Document is current
Any future updates will be listed below
-
Authors
Retseck, Janet
Nasr, Alexis
Lin, Yan
Lin, Huang
Mendiratta, Prateek
Butterfield, Lisa H.
Tarhini, Ahmad A. https://orcid.org/0000-0002-3193-9702
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct00972933 at ClinicalTrials.govDocuments that mention this clinical trial
Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma
https://doi.org/10.1186/s12967-018-1563-y
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (P50 CA121973, P30 CA047904)
Bristol-Myers Squibb (CA184-082)
- License Information
-
More Information
Article History
Received: 20 March 2018
Accepted: 28 June 2018
First Online: 4 July 2018
